More than half of melanoma patients whose cancer initially responds to immunotherapy will eventually see their disease return ...
Lung and skin cancer patients who were taking "checkpoint inhibitors" and had the COVID vaccine saw surprising results.
Early data from a Phase 2 clinical trial show a combination of immunotherapy medications can activate a robust immune ...
Cancer is a complex disease and treating it often involves more than one type of therapy. Radiation treatment is one of the ...
University of Cincinnati reported positive Phase 2 melanoma trial results, with a third of patients responding to a combined ...
Consistent duration of response was observed across PD-L1–positive and negative tumors, as well as in both primary and secondary resistance settings. Median duration of response for PD-L1-negative ...
The Detroit Lions are announcing news on a beloved player who has been sidelined for more than a year following a cancer ...
A protein involved with cell death can be manipulated to slow or reverse tumor growth, a pair of new studies in mice found.
Because aircraft personnel are routinely exposed to galactic cosmic radiation and ultraviolet radiation, they face an elevated risk for certain cancers.
The firm recorded $58 million in sales for the autologous TIL therapy, which it is working on moving into earlier melanoma settings and other tumor types.
Pembrolizumab plus EVX-01, a personalized peptide-based neoantigen cancer vaccine, demonstrated the “ability to induce potent and sustained T-cell responses” among patients with previously untreated, ...
The segment concludes that long-term data reinforce the durability and clinical relevance of combination immunotherapy, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results